Company / SG&A Expense
Molina Healthcare SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$3.0B
FY2025
5-year range
$1.3B / $3.0B
FY2021-FY2025
Trend
+9.7%
vs FY2024
Sector context
#21 of 158
Health Care
What the data says
Molina Healthcare's sg&a expense of $3.0B is higher than 87% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 4 consecutive years, from $1.3B in FY2021 to $3.0B in FY2025.
Based on SEC 10-K filings.
$3.0B in FY2025 with a 5-year CAGR of +15.2%. Top quartile in the Health Care sector.
Increased from $2.5B to $3.0B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +26.7%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 158This company $3.0B Sector average $175.9B
▼
-98.3% below sector average
Key checks
Key Insights
- Molina Healthcare's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +15.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 9.7% year-over-year.
- Ranks #21 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.65 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 21.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0B | +9.7% |
| FY2024 | $2.7B | +11.4% |
| FY2023 | $2.5B | +66.4% |
| FY2022 | $1.5B | +14.2% |
| FY2021 | $1.3B | -12.4% |
| FY2020 | $1.5B | +14.2% |
| FY2019 | $1.3B | -7.0% |
| FY2018 | $1.4B | +21.6% |
| FY2017 | $1.1B | +49.8% |
| FY2016 | $765.0M | -33.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026